Literature DB >> 18695629

Pancreatic islets are very poor in rectifying oxidative DNA damage.

Manisha A Modak1, Pradeep Bhaskar Parab, Saroj S Ghaskadbi.   

Abstract

OBJECTIVE: Free radicals that escape scavenging by antioxidant defense damage lipids, proteins, and DNA. Damage to DNA can be repaired. Therefore, both cells' antioxidant defense and their ability to repair oxidatively damaged DNA decide its fate to survive oxidative stress. Pancreatic islets cells with poor antioxidant defense were checked for their ability to remove oxidative damage form DNA.
METHODS: For ex vivo DNA repair, assay-cultured pancreatic islets and liver slices were treated with 1 and 10 mM H2O2, respectively, for 30 minutes. After incubation for different time intervals, 8-hydroxy-2'-deoxyguanosine (8-OHdG) in DNA of these cells was estimated using monoclonal antibody raised against 8-OHdG by competitive enzyme-linked immunosorbent assay. For in vitro DNA repair assay, oxidatively damaged pBR322 was incubated with nuclear extracts of islet and liver cells, and 8-OHdG retained in the plasmid was quantitated.
RESULTS: Oxidative damage induced by H2O2 was removed quickly and efficiently from DNA by liver cells compared with islet cells. The repair of oxidatively damaged plasmid DNA in vitro was also performed more efficiently (P < 0.05) by nuclear extracts from liver cells compared with islet cell.
CONCLUSIONS: We clearly demonstrate that in addition to their low antioxidant defense, islets are very poor in rectifying the oxidative DNA damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18695629     DOI: 10.1097/MPA.0b013e318181da4e

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  20 in total

1.  Systematic review of islet cryopreservation.

Authors:  Greg G Kojayan; Michael Alexander; David K Imagawa; Jonathan R T Lakey
Journal:  Islets       Date:  2018-01-09       Impact factor: 2.694

Review 2.  Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease.

Authors:  Y Imai; A D Dobrian; J R Weaver; M J Butcher; B K Cole; E V Galkina; M A Morris; D A Taylor-Fishwick; J L Nadler
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

3.  High Recovery of Functional Islets Stored at Low and Ultralow Temperatures.

Authors:  Bhawna Chandravanshi; Anandh Dhanushkodi; Ramesh Bhonde
Journal:  Rev Diabet Stud       Date:  2015-02-10

4.  Production and function of IL-12 in islets and beta cells.

Authors:  D A Taylor-Fishwick; J R Weaver; W Grzesik; S Chakrabarti; S Green-Mitchell; Y Imai; N Kuhn; J L Nadler
Journal:  Diabetologia       Date:  2012-10-03       Impact factor: 10.122

5.  Systematic investigation into the role of intermittent high glucose in pancreatic beta-cells.

Authors:  Chen Shao; Jianqiu Gu; Xin Meng; Hongzhi Zheng; Difei Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  Natural history of β-cell adaptation and failure in type 2 diabetes.

Authors:  Emilyn U Alejandro; Brigid Gregg; Manuel Blandino-Rosano; Corentin Cras-Méneur; Ernesto Bernal-Mizrachi
Journal:  Mol Aspects Med       Date:  2014-12-24

7.  Friendly, and not so friendly, roles of Rac1 in islet β-cell function: lessons learnt from pharmacological and molecular biological approaches.

Authors:  Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2011-02-12       Impact factor: 5.858

8.  Applications of particulate oxygen-generating substances (POGS) in the bioartificial pancreas.

Authors:  John P McQuilling; Sivanandane Sittadjody; Samuel Pendergraft; Alan C Farney; Emmanuel C Opara
Journal:  Biomater Sci       Date:  2017-11-21       Impact factor: 6.843

Review 9.  Redox homeostasis in pancreatic β cells.

Authors:  Petr Ježek; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Oxid Med Cell Longev       Date:  2012-12-13       Impact factor: 6.543

10.  NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction.

Authors:  David A Taylor-Fishwick
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.